The DOI matches its Crossref record; its reference list is not available.
Impaired adrenal cortex reserve in patients with rheumatic and musculoskeletal diseases who relapse upon tapering of low glucocorticoid dose
Abstract
OBJECTIVES: To examine adrenal cortex reserve in patients with rheumatic and musculoskeletal diseases (RMD) who relapse upon tapering of low glucocorticoid dose, despite concomitant treatment with disease-modifying anti-rheumatic drugs (DMARDs). METHODS: A morning standard dose of 250 mcg tetracosactide (Synacthen test) was given in 25 consecutive patients (13 rheumatoid arthritis, 2 psoriatic arthritis, 5 systemic lupus erythematosus, 2 dermatomyositis, 1 systemic sclerosis, 2 temporal arteritis) at the time of relapse upon small reductions (1-2 mg daily) of low prednisolone dose (<7.5 mg daily), while being on stable concomitant treatment with methotrexate, leflunomide, hydroxychloroquine, azathioprine, mycophenolate, tofacitinib, belimumab, anti-TNF, anti-IL-6 or anti-IL-1 regimens (n=14; 3; 9; 1; 2; 1; 1; 5; 2; 1, respectively). Sex-matched apparently healthy individuals (n=45) served as controls. RESULTS: Baseline cortisol levels and time-integrated cortisol response to tetracosactide were lower in patients than controls (12.01±4.47 vs. 15.63±4.16 mcg/dl, p=0.001, and 1050±286 vs. 1284±182, p<0.001, respectively). No significant associations were observed between the cortisol response to tetracosactide and age, duration of disease or glucocorticoid treatment. An abnormal Synacthen test, indicative of adrenal insufficiency, presumably secondary to chronic glucocorticoid administration, was noted in 5/25 patients. The remaining 20 patients (80%) had normal Synacthen test demonstrating, however, lower cortisol response than controls, independently of age (β-coefficient=-0.373, p=0.033). CONCLUSIONS: Patients with RMD in remission under DMARDs who relapse upon concomitant low glucocorticoid dose tapering should be tested for iatrogenic adrenal insufficiency. Whether a marginally normal Synacthen test should discourage further attempts to withdraw glucocorticoid treatment in these patients warrants further investigation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In patients with chronic inflammatory rheumatic diseases including rheumatoid arthritis in remission under DMARDs and low-dose glucocorticoids who relapsed upon tapering, baseline cortisol levels and time-integrated cortisol responses to tetracosactide stimulation were lower than in healthy controls despite the absence of established adrenal insufficiency.
“In these particular patients, we found that both baseline cortisol levels and time-integrated cortisol responses to tetracosactide stimulation (Synacthen test) were lower compared with healthy controls, despite the absence of established adrenal insufficiency.11”
From Diurnal production of cortisol and prediction of treatment response in rheumatoid arthritis: a 6-month, real-life prospective cohort study (2024) · cites this paper as [11]
The reduced adrenal response in these patients was independent of age and disease duration or duration of prior glucocorticoid treatment, pointing to a relative adrenal insufficiency.
“Notably, the reduced adrenal response was independent of age and disease duration or the duration of prior treatment with glucocorticoids, pointing to the presence of a relative adrenal insufficiency in these patients.11”
From Diurnal production of cortisol and prediction of treatment response in rheumatoid arthritis: a 6-month, real-life prospective cohort study (2024) · cites this paper as [11]
The documented efficacy of low-dose prednisone may be related to impaired adrenal reserve in rheumatoid arthritis and supports adding glucocorticoids as replacement therapy.
“Taken together, the documented efficacy of complementary low-dose prednisone may be related to our findings of an impaired adrenal reserve in patients with RA described here and supports the addition of glucocorticoids in RA treatment regimens, as a potential ‘replacement’ therapy.11 58”
From Diurnal production of cortisol and prediction of treatment response in rheumatoid arthritis: a 6-month, real-life prospective cohort study (2024) · cites this paper as [11]
Citations
No citation lists for this paper
No citation lists for this paper yet — checked again daily.
Cited by 5
Metadata
- Authors
- Yavropoulou, M. P., Filippa, M. G., Panopoulos, S., Spanos, E., Spanos, G., Tektonidou, M. G., & Sfikakis, P. P.
- Affiliations
- National and Kapodistrian University of Athens (GR)
- Bioiatriki Health Care Group, Athens, Greece.
- ORCID
- Venue
- Clinical and Experimental Rheumatology
- Published
- 2021-10-12
- Volume
- 40
- Issue
- 9
- Pages
- 1789-1792
- ISSN
- 0392-856X (ISSN-L)
- 1593-098X
- OpenAlex
- W4282944912
- Cited by
- 5
- References
- 0
- Citations by year
- 2025: 1 · 2024: 3 · 2022: 1
- FWCI
- 0.75
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical and Experimental Rheumatology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
- Keywords
- adrenal insufficiency, glucocorticoid tapering, rheumatic and musculoskeletal diseases, ACTH stimulation test, tetracosactide, low-dose prednisolone, recurrence, iatrogenic adrenal insufficiency, disease-modifying antirheumatic drugs, rheumatoid arthritis, systemic lupus erythematosus, dermatomyositis
- MeSH terms
- Leflunomide, Tumor Necrosis Factor Inhibitors, Adrenal Cortex, Adrenal Cortex Hormones, Adrenal Insufficiency, Arthritis, Rheumatoid, Azathioprine, Chronic Disease, Cosyntropin, Glucocorticoids, Humans, Hydrocortisone, Hydroxychloroquine, Methotrexate, Prednisolone, Recurrence, Antirheumatic Agents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review